Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Activated T Cells and IL-2 with Stem Cell Transplant in Metastatic Breast Cancer
NCT00002780Phase 2Unknown
- Sponsor
- St. Luke's Medical Center
- Start
- May 1996
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of LuLym-T, aldesleukin in breast cancer, sponsored by St. Luke's Medical Center. Status: unknown.
02
Drugs
LuLym-Taldesleukin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00002780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002780.